finanzen.net
11.10.2018 15:00
Bewerten
(0)

Bio-Techne To Host Conference Call On October 30, 2018 To Announce First Quarter 2019 Financial Results

DRUCKEN

MINNEAPOLIS, Oct. 11, 2018 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Tuesday, October 30, 2018 at 8:00 a.m. CDT to review first quarter 2019 financial results.

Bio-Techne

Access to the discussion may be obtained as follows:

Time:     8:00 a.m. CDT
Date:      October 30, 2018
Dial-in:   1-866-548-4713 or 1-323-794-2093 (for international callers)
Conference ID:  2296266

A recorded rebroadcast will be available for interested parties unable to participate in the live conference call.  To access the recording, U.S. callers should dial 1-844-512-2921 or international callers should dial 1-412-317-6671 and enter the replay access code 2296266. The recording can also be accessed by going to:  

http://audio.viavid.com/20181030-131762-bio-techne.mp3

The replay will be available from 11:00 a.m. CDT on Tuesday, October 30, 2018 until 11:00 p.m. CDT on Friday, November 30, 2018.

Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies. Bio-Techne's portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, offering researchers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. These reagent and protein analysis solutions are sold to biomedical researchers as well as clinical research laboratories and constitute the Protein Sciences Segment. Bio-Techne also develops and manufactures diagnostic products including FDA-regulated controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM and clinical customers. Bio-Techne's genomic tools include advanced tissue-based in-situ hybridization assays (ISH) for research and clinical use, sold under the ACD brand as well as a portfolio of clinical molecular diagnostic oncology assays, including the ExoDx®Prostate(IntelliScore) test (EPI) for prostate cancer diagnosis. These diagnostic and genomic products comprise Bio-Techne's Diagnostics and Genomics Segment. Bio-Techne products are integral components of scientific investigations into biological processes and molecular diagnostics, revealing the nature, diagnosis, etiology and progression of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $643 million in net sales in fiscal 2018 and has over 2,100 employees worldwide.

Contact:  David Clair, Investor Relations
               ir@bio-techne.com
               646-277-1266  

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/bio-techne-to-host-conference-call-on-october-30-2018-to-announce-first-quarter-2019-financial-results-300729255.html

SOURCE Bio-Techne Corporation

Anzeige
Anzeige
Börse Stuttgart Anlegerclub

Fünf deutsche Internet-Aktien, die Sie kennen sollten!

Das Gute liegt oft so nah. Heimische Internet-Unternehmen rollen den Markt auf. Im neuen Anlegermagazin erwartet Sie ein Special über deutsche Internet-Aktien, die Sie kennen sollten.
Kostenfrei registrieren und lesen!

Heute im Fokus

DAX im Minus -- Akorn legt Berufung im Prozess gegen Fresenius ein -- Erster EZB-Zinsschritt 2019 wegen Italien-Streit später -- Apple kündigt weitere Keynote an

Chinas Wachstum fällt unerwartet stark. Volvo mit Ergebnissprung dank hoher Nachfrage. Porsche stellt klar: Verfolgen derzeit keinen Börsengang. EU sieht schwere Verstöße Italiens gegen Haushaltsregeln. Software AG übertrifft Erwartungen und bestätigt Jahresprognose. American Express steigert Quartalsgewinn um 22 Prozent.

Die 5 beliebtesten Top-Rankings

Die weltweit größten Smartphone-Hersteller
Der Worldwide Quarterly Mobile Phone Tracker
So viel erhalten Bundesliga-Clubs durch Trikotsponsoring
Das Trikotsponsoring der Bundesliga 2018/2019
In diesen Städten leben die Superreichen
Welche Stadt ist besonders beliebt?
Automobilneuheiten-Messe
Neue Studien und Serienfahrzeuge
Best Global Brands 2018
Die Top 20 der wertvollsten Marken weltweit
mehr Top Rankings

Umfrage

Glauben Sie, dass Angela Merkel Anfang Dezember auf dem Parteitag der CDU als Parteichefin wiedergewählt wird?

Online Brokerage über finanzen.net

Das Beste aus zwei Welten: Handeln Sie für nur 5 Euro Orderprovision* pro Trade unmittelbar aus der Informationswelt von finanzen.net!
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Aurora Cannabis IncA12GS7
Wirecard AG747206
Deutsche Bank AG514000
Daimler AG710000
Amazon906866
Deutsche Telekom AG555750
SAP SE716460
EVOTEC AG566480
Steinhoff International N.V.A14XB9
BASFBASF11
Apple Inc.865985
BVB (Borussia Dortmund)549309
CommerzbankCBK100
Volkswagen (VW) AG Vz.766403
TeslaA1CX3T